Conditions: Diabetic Macular Edema Vitrectomy
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 56
Healthy volunteers: no

Brief summary:
The study will evaluate the safety and efficacy of the intravitreal dexamethasone implant in the study eye of vitrectomized subjects with diabetic macular edema. Subjects will be followed for 26 weeks.

Detailed description:

Arms:
arm 1: 700 µg dexamethasone implant in the study eye at Day 1

Interventions: intervention 1: Dexamethasone
Intervention descriptions: intervention 1: 700 µg Dexamethasone Posterior Segment Drug Delivery System Applicator System at Day 1 in the study eye.

Protocol document: